JP Morgan Chase’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-278,500
Closed -$38.6M – 6171
2020
Q3
$38.6M Buy
278,500
+192,100
+222% +$23.4M 0.01% 1109
2020
Q2
$6.5M Buy
+86,400
New +$4.52M ﹤0.01% 2257

JP Morgan Chase's LVGO Position: Q4 2020 in Review

JP Morgan Chase sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 138,785 shares — an estimated $19.2M sold.

JP Morgan Chase first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $19.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • JP Morgan Chase reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 138,785 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19.2M.
  • JP Morgan Chase first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • JP Morgan Chase's Livongo Health, Inc. Common Stock position peaked at $19.2M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.